|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/08 | |
| G01N 33/569 |
| (11) | Patento numeris | 2938631 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14700033.5 |
| Europos patento paraiškos padavimo data | 2014-01-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/050024 |
| Data | 2014-01-02 |
| (87) | Numeris | WO 2014/102399 |
| Data | 2014-07-03 |
| (30) | Numeris | Data | Šalis |
| 12199837 | 2012-12-31 | EP | |
| 201261747541 P | 2012-12-31 | US |
| (72) |
GRIMM, Jan, CH
MARTIN, Roland, CH
COMBALUZIER, Benoit, CH
JELCIC, Ivan, Dr., CH
|
| (73) |
University of Zurich,
Rämistr. 71, 8006 Zurich,
CH
Neurimmune Holding AG, Wagistrasse 13, 8952 Schlieren, CH |
| (54) | RECOMBINANT HUMAN ANTIBODIES FOR THERAPY AND PREVENTION OF POLYOMAVIRUS-RELATED DISEASES |
| RECOMBINANT HUMAN ANTIBODIES FOR THERAPY AND PREVENTION OF POLYOMAVIRUS-RELATED DISEASES |